Company
Headquarters: Beijing, China
Employees: 951
HK$8.58 Billion
HKD as of Jan. 1, 2024
US$1.10 Billion
| Company | Market Cap (USD) |
|---|---|
| Abbott | $192.67 B |
| Stryker Corporation | $113.24 B |
| Medtronic | $111.60 B |
| Boston Scientific Corporation | $85.22 B |
| Shenzhen Mindray Bio-Medical Electronics Co. Ltd | $49.33 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Beijing Chunlizhengda Medical Instruments Co., Ltd., an orthopedic medical device company, engages in the research and development, production, and sale of surgical implants, instruments, and related products in the People's Republic of China. The company offers implantable orthopedic medical devices, which consist of joint prosthesis products and spinal products. It primarily sells its products through distributors, or on ODM and OEM bases under the Chunli brand, as well as to hospitals directly. The company also exports its products to 38 countries and regions in Asia, South America, Africa, Oceania, and Europe. Beijing Chunlizhengda Medical Instruments Co., Ltd. was incorporated in 1998 and is headquartered in Beijing, China.
Top 1-year algo backtest: +284.14%
$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Beijing Chunlizhengda Medical Instruments Co. Ltd has the following listings and related stock indices.
Stock: HKEX: 1858 wb_incandescent